The presence of seven different AAbs related to lung cancer (GAGE7, CAGE, MAGEA1, SOX2, GBU4-5, PGP9.5, and p53) was analyzed in different populations, and the study demonstrated the clinical value of providing a reliable basis for early laboratory diagnosis in patients with early lung cancer. This evidence concerns the gene TP53 and lung carcinoma.